"Abbott touts long-term efficacy for dissolvable Esprit BTK stent" was originally created and published by Medical Device ...

Media tour conducted in conjunction with D S Simon Media discussing Peripheral Artery Disease (PAD), one of the most prevalent diseases that no one has heard of, affecting one in 20 Americans over the ...

Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

Interventional cardiologist Dr. Ross Melvin joins us to give a demonstration of the new technology available to treat peripheral arterial disease.

Following a greenlight from the US FDA, Philips has enrolled the first patient in a trial of its newest intravascular ...